TODD CAMPBELL: Open Payments
NPI 1821603465 · SHREVEPORT, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,083 in 94 payments from 27 companies in 2025. Trend: 2023 $272 · 2024 $2,321 · 2025 $2,083
Food & beverage: $2,015Education: $68
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 10 | $331 |
| Corcept Therapeutics | 6 | $256 |
| Medtronic, Inc. | 13 | $235 |
| Xeris Pharmaceuticals, Inc. | 12 | $210 |
| Astellas Pharma US Inc | 4 | $119 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 5 | $97 |
| Bayer Healthcare Pharmaceuticals Inc. | 5 | $93 |
| RECORDATI_RARE_DISEASES_INC. | 4 | $90 |
| Ascendis Pharma Endocrinology Inc | 4 | $81 |
| ABBVIE INC. | 4 | $73 |
Products named: Korlym, MINIMED 780G, EVENITY, REPATHA, GVOKE HYPOPEN, JARDIANCE, Kerendia, ISTURISA.
Industry payments across LA — which companies pay providers there.
